Autopsy report · NCT00563758
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
Cause of deathNo reason given
Life of this trial
- Registered 2 years 8 months after it had already started.
- Ran for about 1 year 2 months before it stopped.
- 250 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Hospital Authority, Hong Kong
- Sponsor type
- Government (non-US federal)
- Conditions
- Constipation; Chronic Disease
- Interventions
- tegaserod
- Participants
- 250
- Sites
- 1
- Countries
- China
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.